Site Search
Search Results
New Medicare Drug Rule Could Leave Patients Unable to Access Needed Medications
... declined to pay for these drugs. “The countries included through the Most Favored Nation policy have significant differences in their health systems and supply chains and the policy does not appear to take these differences into account. Imposing such significant ... changes—especially in such a short timeframe—could mean some cancer medications are not available, and patients are unable to get essential care. It is also unclear if these changes would save only some patients money or result in cost shifting onto patients with private insurance. ...
Legislative Leadership Expected to Take Up Medicaid Expansion in the 2022 Session
... might change during this session as lawmakers continue to have the most robust conversations on the issue since the passage of the Affordable Care Act and due to a special Medicaid expansion review committee tasked with providing a recommendation on the issue. The below is a statement ... for lifesaving policy this session that will finally ensure over 600,00 hardworking North Carolinians have adequate and affordable access to care necessary to survivorship from cancer and other chronic illnesses. “The 2022 session can be historic for North Carolina. It’ll mean the ... waiting to see lawmakers reinvigorate our rural towns, bring jobs to their neighborhoods, save taxpayer money and support families by improving health for generations to come all by increasing Medicaid eligibility. “We look forward to see the review committee’s recommendations following ...
Expand Access to Biomarker Testing in Pennsylvania
... partners are working together to make sure more Pennsylvanians can benefit from this important testing. What is Biomarker Testing? In cancer care, biomarkers are often used to help determine the best treatment for a patient . A “ biomarker ” is a sign of a normal biological process, ... that have been excluded, including communities of color, individuals with lower socioeconomic status, rural communities, and those receiving care in non-academic medical centers are less likely to receive biomarker testing. Improving coverage for and access to biomarker testing across insurance types is key to reducing health disparities. Insurance coverage for biomarker testing is failing to keep pace with innovations and advancements in treatment. Without action ...
Legislative Action Needed to Reduce the Burden of Cancer on Illinoisans
... in our state. If passed, the state program would allow those impacted by cancer to take time off work to attend to their own or a loved one’s care without losing their job or income. ACS CAN looks forward to working with the general assembly this year to pass this crucial ... advocacy affiliate, ACS CAN has successfully advocated for billions of dollars in cancer research funding, expanded access to quality affordable health care, and advanced proven tobacco control measures. We’re more determined than ever to stand together with our volunteers to end cancer as we ...
Cancer Patients and Survivors Return to the Capitol to Rally Legislators
... the right time,’ precision medicine has played a critical role in improving cancer outcomes. Passing this legislation would improve access to care and reduce the burden of cancer on Kentuckians. Roughly 30,270 Kentucky residents will be diagnosed with cancer this year. Having access to ... advocacy affiliate, ACS CAN has successfully advocated for billions of dollars in cancer research funding, expanded access to quality affordable health care, and advanced proven tobacco control measures. We’re more determined than ever to stand together with our volunteers to end cancer as we ...
Oncologists to Visit New York State Capitol & Urge Legislators to Improve Access to Biomarker Testing
... – a tool that opens the door to precision medicine. WHAT: Improving Access to Biomarker Testing: Opportunity to Revolutionize Cancer Care in New York WHO: Oncologists, cancer survivors and patient advocates representing ACS CAN to host press conference on biomarker testing ... oncologists and policy experts on how biomarker testing can improve survival outcomes and patients’ quality of life, often with reduced health care costs for the state. Members of the media are invited to attend the press conference and interview volunteers, oncologists and ACS CAN staff ...
General Assembly Misses Opportunity to Reduce the Burden of Cancer
... cancer in our state. The legislation would have allowed those impacted by cancer to take time off work to attend to their own or a loved one’s care without losing their job or income. “ACS CAN looks forward to hopefully working with the General Assembly during the veto session this ... advocacy affiliate, ACS CAN has successfully advocated for billions of dollars in cancer research funding, expanded access to quality affordable health care, and advanced proven tobacco control measures. We stand with our volunteers, working to make cancer a top priority for policymakers in cities, ...
Letter to the Editor: Cancer fight top priority from Higganum to D.C.
... I met with Joe Dunn, senior policy advisor to Sen. Chris Murphy (D-Connecticut), I thanked the senator for being a co-sponsor of the Palliative Care and Hospice Education and Training Act. He is on the Health Education Labor Pensions Committee, and I urged him to persuade Chairman Lamar Alexander to schedule this for a vote. As a cancer survivor, I have benefited greatly from palliative care, and I think it should be available to all cancer patients and survivors. I also let our lawmakers know that the people of Connecticut, and ...
Lawmakers Take Critical Step to Revolutionize Cancer Treatment in North Carolina
... the legislation would allow more North Carolinians to access biomarker testing, which has become an increasingly important part of cancer care. Patients who are diagnosed with certain types of cancer can receive biomarker testing to help providers determine the most effective form of ... testing can help save critical time in a cancer fight. This form of precision medicine has become widely used and relied upon in cancer care in recent years, and it’s increasingly important for other disease areas as well. Unfortunately, some people are not benefiting from the ... aligning coverage for biomarker testing with the latest science, we can help increase access to precision medicine that can save lives, improve health outcomes and potentially reduce costs ,” said John Broome , government relations director for the American Cancer Society Cancer Action ...
Defending Choice of Provider for Medicaid Beneficiaries
A case recently decided at the Supreme Court of the United States (SCOTUS) could have a major impact on access to care for Medicaid patients. The Medicaid Act has a provision stating that beneficiaries must be able to choose from “any qualified provider” for their care. Congress wrote this provision because states were forcing Medicaid beneficiaries to go to state affiliated providers like state ... in disease prevention and treatment, as well as extensive scientific research showing a strong link between access to Medicaid and improved health outcomes, with an emphasis on the critical role Medicaid plays in rural areas. The brief included original research published by the ...
Type
- Action (13) Apply Action filter
- Basic page (238) Apply Basic page filter
- Event (22) Apply Event filter
- Landing Page (5) Apply Landing Page filter
- Press Release (2195) Apply Press Release filter
- Resource (49) Apply Resource filter
- State Priority (195) Apply State Priority filter
- Update (1163) Apply Update filter
Priority Issue
State
- National (483) Apply National filter
- Maine (219) Apply Maine filter
- New York (214) Apply New York filter
- Massachusetts (196) Apply Massachusetts filter
- Vermont (184) Apply Vermont filter
- New Jersey (98) Apply New Jersey filter
- Pennsylvania (77) Apply Pennsylvania filter
- Ohio (73) Apply Ohio filter
- Maryland (72) Apply Maryland filter
- California (70) Apply California filter
- North Carolina (70) Apply North Carolina filter
- Connecticut (69) Apply Connecticut filter
- Florida (60) Apply Florida filter
- Georgia (50) Apply Georgia filter
- Missouri (49) Apply Missouri filter
- Kentucky (48) Apply Kentucky filter
- Wisconsin (44) Apply Wisconsin filter
- Illinois (43) Apply Illinois filter
- Montana (43) Apply Montana filter
- West Virginia (43) Apply West Virginia filter
- Michigan (42) Apply Michigan filter
- South Carolina (42) Apply South Carolina filter
- Alabama (41) Apply Alabama filter
- Kansas (41) Apply Kansas filter
- Oklahoma (40) Apply Oklahoma filter
- Tennessee (40) Apply Tennessee filter
- Mississippi (39) Apply Mississippi filter
- Indiana (38) Apply Indiana filter
- Minnesota (38) Apply Minnesota filter
- Texas (37) Apply Texas filter
- Virginia (37) Apply Virginia filter
- South Dakota (36) Apply South Dakota filter
- Colorado (33) Apply Colorado filter
- Idaho (32) Apply Idaho filter
- Wyoming (32) Apply Wyoming filter
- Arizona (30) Apply Arizona filter
- Oregon (30) Apply Oregon filter
- Louisiana (29) Apply Louisiana filter
- Arkansas (28) Apply Arkansas filter
- Washington (27) Apply Washington filter
- New Mexico (26) Apply New Mexico filter
- Rhode Island (26) Apply Rhode Island filter
- Nebraska (25) Apply Nebraska filter
- Iowa (24) Apply Iowa filter
- Nevada (24) Apply Nevada filter
- New Hampshire (24) Apply New Hampshire filter
- Utah (24) Apply Utah filter
- Delaware (20) Apply Delaware filter
- Hawaii (20) Apply Hawaii filter
- Alaska (17) Apply Alaska filter
Policy Issue
- Access to Health Care (9) Apply Access to Health Care filter
- Prevention and Early Detection (9) Apply Prevention and Early Detection filter
- Health Equity (7) Apply Health Equity filter
- Research, Funding and Drug Development (6) Apply Research, Funding and Drug Development filter
- Patient Quality of Life (3) Apply Patient Quality of Life filter